The discriminative stimulus effects of N-methyl-d-aspartate glycine-site ligands in NMDA antagonist-trained rats

Psychopharmacology

Volumn 203, Issue 2, 2009, Pages 441-451

  Nicholson, Katherine L ^a   Balster, Robert L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Drug discrimination; Glycine site; NMDA antagonists; NPC 17742; Phencyclidine; Rats

Indexed keywords

1 AMINOCYCLOPROPANE 1 CARBOXYLIC ACID METHYL ESTER; 2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 3 (2 CARBOXY 2 PHENYLETHENYL) 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; 3 (BENZOYLMETHYLAMINO) 6 CHLORO 1H INDOLE 2 CARBOXYLIC ACID; 3 [2 (3 AMINOPHENYL) 2 CARBOXYETHENYL] 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 4 CARBOXYMETHYLAMINO 5,7 DICHLORO 2 QUINOLINECARBOXYLIC ACID; 5 AZA 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL)QUINOLINE 2(1H) ONE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; 8 CHLORO 4 HYDROXY 1 OXO 1,2 DIHYDROPYRIDAZINO[4,5 B]QUINOLINE 5 OXIDE; 8 FLUORO 4 HYDROXY 1 OXO 1,2 DIHYDROPYRIDAZINO[4,5 B]QUINOLINE 5 OXIDE; ACEA 0762; CARBOXYLIC ACID DERIVATIVE; CYCLOPROPANE DERIVATIVE; GLYCINE RECEPTOR AGONIST; GLYCINE RECEPTOR ANTAGONIST; LIGAND; MDL 100458; MDL 103371; MDL 104472; MRZ 2 571; MRZ 2 576; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG BINDING SITE; DRUG DISCRIMINATION; DRUG POTENCY; DRUG SELECTIVITY; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACIDS; ANIMALS; BEHAVIOR, ANIMAL; BINDING SITES; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 62449107334     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1469-8     Document Type: Article

References (55)

1. Balster RL (1991) Discriminative stimulus properties of phencyclidine and other NMDA antagonists. In: Glennon RA, Järbe TUC, Frankenheim J (eds) Drug discrimination: Applications to drug abuse research, National Institute on Drug Abuse Research Monograph Series 116, DHHS Publication No.(ADM) 92-1878. U.S. Government Printing Office, Washington DC, pp 163-180
2. RL Balster RS Mansbach KL Shelton KL Nicholson DM Grech JL Wiley H Li E Weber 1995 Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists Behav Pharmacol 6 577 589
3. BM Baron BL Harrison IA McDonald BS Meldrum MG Palfreyman FG Salituro BW Siegel AL Slone JP Turner HS White 1992 Potent indole- and quinoline-containing N-methyl-d-aspartate antagonists acting at the strychnine-insensitive glycine binding site J Pharmacol Exp Ther 262 947 956
4. BM Baron BL Harrison JH Kehne CJ Schmidt PL van Giersbergen HS White BW Siegel Y Senyah TC McCloskey GM Fadayel VL Taylor MK Murawsky P Nyce FG Salituro 1997 Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist Eur J Pharmacol 323 181 192
5. PM Beardsley E Ratti RL Balster J Willetts D Trist 2002 The selective glycine antagonist gavestinel lacks phencyclidine-like behavioral effects Behav Pharmacol 13 583 592
6. P Berger K Farrel F Sharp P Skolnick 1994 Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex Neurosci Lett 168 147 150
7. DJ Bobelis RL Balster 1993 Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7- phosphonoheptanoic acid (NPC 12626), a competitive N-methyl-d-aspartate receptor antagonist J Pharmacol Exp Ther 264 845 853
8. A Bourson MD Tricklebank 1991 The discriminative stimulus properties of the glycine/NMDA receptor antagonist L-687,414 Fund Clin Pharmacol 5 443
9. LJ Bristow L Landon KL Saywell MD Tricklebank 1995 The glycine/NMDA antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat Psychopharmacology 118 230 232
10. Browne RG (1982) Discriminative stimulus properties of phencyclidine. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier, Amsterdam, pp 109-122
11. W Danysz CG Parsons 1998 Glycine and N-methyl-d-aspartate receptors: Physiological significance and possible therapeutic applications Pharmacol Rev 50 597 664
12. W Danysz E Kozela CG Parsons M Sladek T Bauer P Popik 2005 Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance Neuropharmacology 48 360 371
13. SM Davis KR Lees GW Albers HC Diener S Markabi G Karlsson J Norris 2000 Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist Stroke 31 347 354
14. AG Dyker KR Edwards PB Fayad JT Hormes KR Lees 1999 Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke Stroke 30 2038 2042
15. JW Ferkany DJ Kyle J Willetts WJ Rzeszotarski ME Guzewska SR Ellenberger SM Jones AI Sacaan LD Snell S Borosky BE Jones KM Johnson RL Balster K Burchett K Kawasaki DB Hoch R Dingledine 1989 Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist J Pharmacol Exp Ther 250 100 109
16. B Geter-Douglass JM Witkin 1997 Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice Psychopharmacology 133 43 50
17. G Gigler G Szénási A Simó G Lévay LG Hársing Jr K Sas L Vécsei J Toldi 2007 Neuroprotective effect of l-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils Eur J Pharmacol 564 116 122
18. LH Gold RL Balster 1993 Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA receptor antagonist NPC 12626 from saline Eur J Pharmacol 230 285 292
19. KA Grant G Colombo J Grant MA Rogawski 1996 Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists Neuropharmacology 35 1709 1719
20. MB Hesselink H Smolders B Eilbacher AG De Boer DD Breimer W Danysz 1999 The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-d-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies J Pharmacol Exp Ther 290 543 550
21. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MA, Cowan A (eds) Testing and evaluation of drugs of abuse. Wiley-Liss, New York, pp 193-210
22. M Karcz-Kubicha M Jessa M Nazar A Plaznik S Hartmann CG Parsons W Danysz 1997 Anxiolytic activity of glycine-B antagonists and partial agonists-no relation to intrinsic activity in the patch clamp Neuropharmacology 36 1355 1367
23. JH Kehne BM Baron BL Harrison TC McCloskey MG Palfreyman M Poirot FG Salituro BW Siegel AL Slone PL Van Giersbergen 1995 MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles Eur J Pharmacol 284 109 118
24. NW Kleckner R Dingledine 1988 Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes Science 241 835 837
25. W Koek 1999 N-methyl-d-aspartate antagonists and drug discrimination Pharmacol Biochem Behav 64 275 281
26. Koek W, Colpaert FC (1992) N-methyl-d-aspartate antagonism and phencyclidine-like activity: behavioral effects of glycine site ligands. In: Kamenka JM, Domino EF (eds) Multiple sigma and PCP receptor ligands: mechanisms for neuromodulation and neuroprotection. NPP Books, Ann Arbor, Michigan, pp 655-671
27. W Koek JH Woods FC Colpaert 1990 N-methyl-d-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis J Pharmacol Exp Ther 253 1017 1025
28. W Koek FC Colpaert J Vignon 1993 Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection J Pharmacol Exp Ther 264 746 756
29. PD Leeson LL Iverson 1994 The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential J Med Chem 37 4053 4067
30. T Lipina V Labrie I Weiner J Roder 2005 Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia Psychopharmacology 179 54 67
31. K Lufty SX Cai RM Woodward E Weber 1997 Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice Pain 70 31 40
32. RS Mansbach RL Balster 1991 Pharmacological specificity of the phencyclidine discriminative stimulus in rats Pharmacol Biochem Behav 39 971 975
33. MJ Millan L Seguin 1994 Chemically-diverse ligands at the glycine B site coupled to N-methyl-d-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice Neurosci Lett 178 139 143
34. KL Nicholson RL Balster 2002 Evaluation of the discriminative stimulus effects of the low-affinity N-methyl-d-aspartate channel blockers AR-R 13950AA and AR-R 16283AA in rats and rhesus monkeys Behav Pharmacol 13 571 581
35. KL Nicholson RL Balster 2003 Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats Psychopharmacoogy 170 215 224
36. KL Nicholson HE Jones RL Balster 1998 Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-d-aspartate channel blocker memantine Behav Pharmacol 9 231 243
37. CG Parsons W Danysz G Quack S Hartmann B Lorenz C Wollenburg L Baran E Przegalinski W Kostowski P Krzascik B Chizh PM Headley 1997 Novel systemically active antagonists of the glycine site of the N-methyl-d-aspartate receptor: electrophysiological, biochemical and behavioral characterization J Pharmacol Exp Ther 283 1264 1275
38. MA Petty C Neumann-Haefelin J Kalisch S Sarhan JG Wettstein HP Juretschke 2003 In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke Eur J Pharmacol 474 53 62
39. T Priestley JA Kemp 1994 Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-d-aspartic acid receptor complex Mol Pharmacol 46 1191 1196
40. T Priestley P Laughton AJ Macaulay RG Hill JA Kemp 1996 Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324 Neuropharmacology 35 1573 1581
41. BL Schwartz S Hashtroudi RL Herting P Schwartz SI Deutsch 1996 d-Cycloserine enhances implicit memory in Alzheimer patients Neurology 46 420 424
42. L Singh AE Donald AC Foster PH Hutson LL Iversen SD Iversen JA Kemp PD Leeson GR Marshall RJ Oles 1990 Enantiomers of HA-966 (3-amino-1- hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-d-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative Proc Natl Acad Sci 87 347 351
43. L Singh R Menzies MD Tricklebank 1990 The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-d-aspartate receptor Eur J Pharmacol 186 129 132
44. MD Temple RJ Hamm 1996 Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury Brain Res 741 246 251
45. MD Tricklebank L Singh RJ Oles C Preston SD Iversen 1989 The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor Eur J Pharmacol 167 127 135
46. R Trullas T Folio A Young R Miller K Boje P Skolnick 1991 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models Eur J Pharmacol 203 379 385
47. E Viu A Zapata J Capdevila P Skolnick R Trullas 2000 Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning Neurobiol Learn Mem 74 146 160
48. JM Witkin S Brave D French B Geter-Douglass 1995 Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor J Pharmacol Exp Ther 275 1267 1273
49. JM Witkin TD Steele LG Sharpe 1997 Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline J Pharmacol Exper Ther 280 46 52
50. JL Wiley RL Balster 1994 Effects of competitive and non-competitive N-methyl-d-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle Psychopharmacology 116 266 272
51. JL Wiley H Li RL Balster 1997 Discriminative stimulus effects of site-selective N-methyl-d-aspartate antagonists in NPC 17742-trained rats and squirrel monkeys Psychopharmacology 132 382 388
52. J Willetts RL Balster 1988 The discriminative stimulus effects of N-methyl-d-aspartate antagonists in phencyclidine-trained rats Neuropharmacology 27 1249 1256
53. J Willetts DJ Bobelis RL Balster 1989 Drug discrimination based on the competitive N-methyl-d-aspartate antagonist, NPC 12626 Psychopharmacology 99 458 462
54. J Willetts RL Balster JD Leander 1990 The behavioral pharmacology of NMDA receptor antagonists Trends Pharmacol Sci 11 423 428
55. PL Wood 2005 The NMDA receptor complex: a long and winding road to therapeutics Idrugs 8 229 235